世界の放射線手術装置市場2021年-2031年:種類別(ガンマナイフ装置、リニア加速装置、陽子線治療)、病態別、エンドユーザー別

【英語タイトル】Radiosurgery Systems Market By Type (Gamma Knife system, Linear accelerator systems, Proton beam therapy), By Condition (Brain Tumors, Spine Tumors), By End User (Hospitals, Academic and Research institute): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料(ALD22NV0056)・商品コード:ALD22NV0056
・発行会社(調査会社):Allied Market Research
・発行日:2022年7月
・ページ数:315
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,820 ⇒換算¥861,360見積依頼/購入/質問フォーム
5 UserUSD6,630 ⇒換算¥981,240見積依頼/購入/質問フォーム
Enterprise UserUSD10,500 ⇒換算¥1,554,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社の本調査資料では、世界の放射線手術装置市場規模が2021年2,095.2百万ドルから2031年3,979.2百万ドルに達し、2022年から2031年まで年平均6.7%成長すると予測しています。当書は、放射線手術装置の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、種類別(リニア加速装置、陽子線治療、ガンマナイフ装置)分析、病態別(脳腫瘍、脊椎腫瘍)分析、エンドユーザー別(病院、学術&研究機関)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、ACCURAY INCORPORATED、Elekta AB、Atrium Health、Avocure、Brainlab、Integra LifeSciences Holding Corp、Ion Beam Applications SA、Medtronic、Mevion Medical Systems, Inc.、Nordion Inc.、RefleXion Medical、Siemens (Varian Medical Systems)などが含まれております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の放射線手術装置市場規模:種類別
- リニア加速装置の市場規模
- 陽子線治療の市場規模
- ガンマナイフ装置の市場規模
・世界の放射線手術装置市場規模:病態別
- 脳腫瘍における市場規模
- 脊椎腫瘍における市場規模
・世界の放射線手術装置市場規模:エンドユーザー別
- 病院における市場規模
- 学術&研究機関における市場規模
・世界の放射線手術装置市場規模:地域別
- 北米の放射線手術装置市場規模
- ヨーロッパの放射線手術装置市場規模
- アジア太平洋の放射線手術装置市場規模
- 中南米・中東・アフリカの放射線手術装置市場規模
・企業状況
・企業情報

The global radiosurgery systems market was valued at $2,095.2 million in 2021, and is projected to reach $3,979.2 million by 2031, registering a CAGR of 6.7% from 2022 to 2031.
An extremely accurate type of therapeutic radiology is radiosurgery, often known as stereotactic radiosurgery. Despite the name surgery, which implies actual surgery, radiosurgery is a single radiation therapy session that mimics the effects of a surgical procedure. Radiosurgery is a minimally invasive procedure that treats tumors and other issues in the brain, neck, lungs, liver, spine, and other areas of the body by using a large number of precisely focused radiation beams. Furthermore, stereotactic radiosurgery harms the DNA of the targeted cells, just like other radiation treatments do. Tumors then contract as the damaged cells lose their capacity to procreate.
Radiosurgery can be used to treat many conditions in the brain such as blood vessel disorders like arteriovenous malformation, trigeminal neuralgia, epilepsy and other. Mainly radiosurgery is used in primary brain tumor which includes pituitary tumor, meningioma, glioma, acoustic neuroma, hemangioblastoma, pediatric brain tumor, metastatic tumors and others. Moreover, radiosurgery is used to treat cancer disease.
The radiosurgery systems market is driven by rise in prevalence of cancer, technological advancement in development of radiosurgery systems, rise in the number of product launch and product approval for radiosurgery system. For instance, according to World Cancer Research Fund International, it was reported that 18,094,716 cancer cases were diagnosed over the globe. Moreover, according to World Health Organization, (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed worldwide. In addition, rise in the number of brain cancer, brain tumor and spinal cord tumor increases the demand of radiosurgery systems for treatment purpose. For instance, according to World Cancer Research Fund International, it was reported that 308,102 brain, central nervous system cancer cases were diagnosed over the globe.
The global radiosurgery systems market is predicted to develop as more patients battle brain tumors, which cause increase in the shift of consumer preference toward minimally invasive and non-invasive techniques. The use of minimally invasive radiosurgery is supported by a number of advantages, including quicker healing, lower morbidity and mortality, and shorter hospital stays.
Geriatric population is more susceptible to chronic diseases. Rise in number of geriatric populations increases the demand of radiosurgery systems for cancer treatment. Thus, this factor contributes to drive the growth of radiosurgery systems market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for in radiosurgery systems application in different disease treatment, thereby boosting the market growth. On the other hand, high cost associated with radiosurgery systems and side effects of radiosurgery attributes to hinder market growth.    
The radiosurgery systems market is segmented on the basis of type, condition, end user and region. On the basis of type the market is segmented into gamma knife system, linear accelerator systems and proton beam therapy. On the condition market is segmented into brain tumors and spine tumor. Brain tumor is further bifurcated into malignant and non-malignant. Malignant segment further sub-categorized into Meningioma, pituitary tumor and others. Non-malignant further sub categorized into Glioblastoma, Anaplastic astrocytoma and others. On the end user, market is bifurcated into hospitals and academic & research institute. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global radiosurgery systems market include Accuray Incorporated, Elekta AB, Atrium Health, Avocure, Brain LAB, Integra Life Sciences Holding Corp, Ion Beam Applications SA, Medtronic, Mevion Medical Systems, Inc., Nordion Inc., Reflexion Medical, Siemens (Varian Medical Systems), Summit Cancer Centers, ViewRay, Vision RT, Xcision Medical Systems, ZAP surgical System Inc.                

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the radiosurgery systems market analysis from 2021 to 2031 to identify the prevailing radiosurgery systems market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the radiosurgery systems market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global radiosurgery systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type
● Linear accelerator systems
● Proton beam therapy
● Gamma Knife system

By Condition
● Brain Tumors
○ Type
○ Malignant
○ Non malignant
● Spine Tumors

By End User
● Hospitals
● Academic and Research institute

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA

● Key Market Players
○ ACCURAY INCORPORATED
○ Elekta AB
○ Atrium Health
○ Avocure
○ Brainlab
○ Integra LifeSciences Holding Corp
○ Ion Beam Applications SA
○ Medtronic
○ Mevion Medical Systems, Inc.
○ Nordion Inc.
○ RefleXion Medical
○ Siemens (Varian Medical Systems)
○ Summit Cancer Centers
○ ViewRay
○ vision rt ltd
○ Xcision Medical Systems
○ ZAP surgical System Inc.

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: RADIOSURGERY SYSTEMS MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Gamma Knife system
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Linear accelerator systems
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Proton beam therapy
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: RADIOSURGERY SYSTEMS MARKET, BY CONDITION
5.1 Overview
5.1.1 Market size and forecast
5.2 Brain Tumors
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Brain Tumors Radiosurgery Systems Market by Type
5.3 Spine Tumors
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: RADIOSURGERY SYSTEMS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Academic and Research institute
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: RADIOSURGERY SYSTEMS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Condition
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Condition
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Condition
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Condition
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Condition
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Condition
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Condition
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Condition
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Condition
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Condition
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Condition
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Condition
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Condition
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Condition
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Condition
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Condition
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Condition
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Condition
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Condition
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Condition
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 South Africa
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Condition
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Condition
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Condition
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 ACCURAY INCORPORATED
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Elekta AB
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Atrium Health
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Avocure
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Brainlab
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Integra LifeSciences Holding Corp
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Ion Beam Applications SA
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Medtronic
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Mevion Medical Systems, Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Nordion Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 RefleXion Medical
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Siemens (Varian Medical Systems)
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Summit Cancer Centers
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 ViewRay
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 vision rt ltd
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 Xcision Medical Systems
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 ZAP surgical System Inc.
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments



★調査レポート[世界の放射線手術装置市場2021年-2031年:種類別(ガンマナイフ装置、リニア加速装置、陽子線治療)、病態別、エンドユーザー別] (コード:ALD22NV0056)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の放射線手術装置市場2021年-2031年:種類別(ガンマナイフ装置、リニア加速装置、陽子線治療)、病態別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆